Similar articles

• Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

  Abbas UL, Mellors JW. Abbas UL, et al. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13377-8. doi: 10.1073/pnas.212518999. Epub 2002 Oct 7. Proc Natl Acad Sci U S A. 2002. PMID: 12370421 Free PMC article. Review. No abstract available.
• Antiretroviral therapy for HIV: drug resistance and sequencing.

  Burkle WS. Burkle WS. J Assoc Nurses AIDS Care. 2002 Jan-Feb;13(1):76-80. doi: 10.1016/S1055-3290(06)60243-4. J Assoc Nurses AIDS Care. 2002. PMID: 11828862 Review. No abstract available.
• [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].

  Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL. Li H, et al. Zhonghua Yi Xue Za Zhi. 2007 Nov 13;87(42):2973-6. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18261327 Clinical Trial. Chinese.
• Antiretroviral treatment in HIV infection.

  Raines CP. Raines CP. Lippincotts Prim Care Pract. 2000 Jan-Feb;4(1):83-100. Lippincotts Prim Care Pract. 2000. PMID: 11022522 Review. No abstract available.
• Patients who want to stop their medications: treatment interruptions in HIV infection.

  Ball SC. Ball SC. AIDS Read. 2003 Jul;13(7):317-9, 324, 342. AIDS Read. 2003. PMID: 12889449 Review. No abstract available.